SCHEMBL25388142

SCHEMBL25388142

C[Si](C)(C)CCOCn1nc(Cl)nc1Cl

nearest known ligand 0.39

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 1/20 0.39
▸ TP53 P04637 1/20 0.35
▸ DGAT1 O75907 3/20 0.33
▸ TSHR P16473 1/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ GAA P10253 1/20 0.31
▸ USP2 O75604 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20306595 0.83 DGAT1 (0.37) DGAT1
SCHEMBL27864622 0.79 F11 (0.32) KMT2ADGAT1
SCHEMBL16387218 0.79 NPC1 (0.33) KMT2ADGAT1
SCHEMBL3079979 0.76 F2 (0.34) KMT2ADGAT1ALDH1A1
SCHEMBL23130519 0.73 DGAT1 (0.31) DGAT1
SCHEMBL27228003 0.71 — —
SCHEMBL30496013 0.70 — —
SCHEMBL23986534 0.70 — —
SCHEMBL21631566 0.70 DGAT1 (0.33) DGAT1
SCHEMBL20489156 0.70 DGAT1 (0.34) DGAT1ALDH1A1KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023173057-A1 MEK INHIBITORS AND USES THEREOF Ikena Oncology, Inc. (US) 2023-09-14 — — WO disclosed
WO-2023173057-A1 MEK INHIBITORS AND USES THEREOF Ikena Oncology, Inc. (US) 2023-09-14 — — WO disclosed
Send feedback